SSY Group Limited (HKG:2005)

Market Cap	6.74B -24.7%
Revenue (ttm)	4.17B -27.8%
Net Income	470.64M -55.6%
EPS	0.16 -55.2%
Shares Out	2.89B
PE Ratio	14.52
Forward PE	11.64
Dividend	0.08 (3.43%)
Ex-Dividend Date	May 20, 2026

Volume	9,030,000
Open	2.330
Previous Close	2.330
Day's Range	2.300 - 2.400
52-Week Range	2.240 - 3.400
Beta	0.46
Analysts	Strong Buy
Price Target	3.76 (+60.0%)
Earnings Date	Aug 28, 2026

About SSY Group

SSY Group Limited, an investment holding company, researches, develops, manufactures, trades, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 5,472
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2005

Financial Performance

In 2025, SSY Group's revenue was 4.17 billion, a decrease of -27.85% compared to the previous year's 5.77 billion. Earnings were 470.64 million, a decrease of -55.65%.